Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 3
1996 4
1997 6
1998 9
1999 16
2000 18
2001 16
2002 24
2003 21
2004 36
2005 34
2006 22
2007 17
2008 20
2009 8
2010 12
2011 10
2012 12
2013 19
2014 10
2015 9
2016 8
2017 8
2018 3
2019 10
2020 14
2021 18
2022 12
Text availability
Article attribute
Article type
Publication date

Search Results

374 results
Results by year
Filters applied: . Clear all
Page 1
Targeting OCT3 attenuates doxorubicin-induced cardiac injury.
Huang KM, Zavorka Thomas M, Magdy T, Eisenmann ED, Uddin ME, DiGiacomo DF, Pan A, Keiser M, Otter M, Xia SH, Li Y, Jin Y, Fu Q, Gibson AA, Bonilla IM, Carnes CA, Corps KN, Coppola V, Smith SA, Addison D, Nies AT, Bundschuh R, Chen T, Lustberg MB, Wang J, Oswald S, Campbell MJ, Yan PS, Baker SD, Hu S, Burridge PW, Sparreboom A. Huang KM, et al. Among authors: sparreboom a. Proc Natl Acad Sci U S A. 2021 Feb 2;118(5):e2020168118. doi: 10.1073/pnas.2020168118. Proc Natl Acad Sci U S A. 2021. PMID: 33495337 Free PMC article.
Drug transporters and anthracycline-induced cardiotoxicity.
Huang KM, Hu S, Sparreboom A. Huang KM, et al. Among authors: sparreboom a. Pharmacogenomics. 2018 Jul 1;19(11):883-888. doi: 10.2217/pgs-2018-0056. Epub 2018 Jul 11. Pharmacogenomics. 2018. PMID: 29991332 Review.
MATE1 Deficiency Exacerbates Dofetilide-Induced Proarrhythmia.
Uddin ME, Eisenmann ED, Li Y, Huang KM, Garrison DA, Talebi Z, Gibson AA, Jin Y, Nepal M, Bonilla IM, Fu Q, Sun X, Millar A, Tarasov M, Jay CE, Cui X, Einolf HJ, Pelis RM, Smith SA, Radwański PB, Sweet DH, König J, Fromm MF, Carnes CA, Hu S, Sparreboom A. Uddin ME, et al. Among authors: sparreboom a. Int J Mol Sci. 2022 Aug 3;23(15):8607. doi: 10.3390/ijms23158607. Int J Mol Sci. 2022. PMID: 35955741 Free PMC article.
Pharmacogenomics in Cytotoxic Chemotherapy of Cancer.
Talebi Z, Sparreboom A, Colace SI. Talebi Z, et al. Among authors: sparreboom a. Methods Mol Biol. 2022;2547:63-94. doi: 10.1007/978-1-0716-2573-6_4. Methods Mol Biol. 2022. PMID: 36068461 Review.
Drug Transporters: Advances and Opportunities.
Govindarajan R, Sparreboom A. Govindarajan R, et al. Among authors: sparreboom a. Clin Pharmacol Ther. 2016 Nov;100(5):398-403. doi: 10.1002/cpt.454. Clin Pharmacol Ther. 2016. PMID: 27718234
Irinotecan pharmacogenetics: a finished puzzle?
Phelps MA, Sparreboom A. Phelps MA, et al. Among authors: sparreboom a. J Clin Oncol. 2014 Aug 1;32(22):2287-9. doi: 10.1200/JCO.2014.56.3387. Epub 2014 Jun 23. J Clin Oncol. 2014. PMID: 24958823 No abstract available.
Pharmacogenomic importance of ABCG2.
Cusatis G, Sparreboom A. Cusatis G, et al. Among authors: sparreboom a. Pharmacogenomics. 2008 Aug;9(8):1005-9. doi: 10.2217/14622416.9.8.1005. Pharmacogenomics. 2008. PMID: 18681776 Free article. Review.
Pharmacogenetics of drug transporters.
Franke RM, Gardner ER, Sparreboom A. Franke RM, et al. Among authors: sparreboom a. Curr Pharm Des. 2010;16(2):220-30. doi: 10.2174/138161210790112683. Curr Pharm Des. 2010. PMID: 19835554 Review.
374 results